Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/308,883external-prioritypatent/US5576300A/en
Application filed by Abbott Lab, Univ OklahomafiledCriticalAbbott Lab
Publication of NZ333652ApublicationCriticalpatent/NZ333652A/en
This use of native or recombinant unhydrolyzed human or bovine k-casein (kappa-casein) is in medicaments for treating or retarding the onset of human rotavirus.
NZ333652A1994-09-161999-01-06Inhibition of human rotavirus infection using kappa-casein
NZ333652A
(en)